Provider groups and health systems warn tariffs will test healthcare’s fragile supply chain, and Wall Street said medtech businesses will face pressure, particularly diabetes tech firms.

The framework helps clinicians choose phrases that more accurately reflect the likelihood that certain conditions are present in X-rays.